Tongue hyperpigmentation during interferon-alpha and ribavirin therapy.
Aguayo-Leiva
Ingrid
I
Pérez
Bibiana
B
Salguero
Irene
I
Jaén
Pedro
P
D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced* / Q000175:diagnosis; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D012254:Ribavirin / Q000008:administration & dosage / Q000009:adverse effects*; D014060:Tongue Diseases / Q000139:chemically induced* / Q000175:diagnosis
D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin